Medicenna Therapeutics Corp. Description Of Option Life Share Options Granted
Medicenna Therapeutics Corp. (MDNAF) reported Description Of Option Life Share Options Granted of 500.00% for the 12-month period ending 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Notes
ifrs-full:DescriptionOfOptionLifeShareOptionsGranted · last filed 2023-06-27
| Period end | Description Of Option Life Share Options Granted 12 month |
|---|---|
| 2023-03-31 | 500.00% 20-F · filed 2023-06-27 |
| 2022-03-31 | 500.00% 20-F · filed 2023-06-27 |
| 2021-03-31 | 500.00% 20-F · filed 2023-06-27 |